Neoplasm of thorax

Related records

Broader conditions (6)

• Cancer or benign tumor
• Disease
• Disease by etiologic mechanism
• Human disease
• Neoplasm
• Neoplastic disease or syndrome

Narrower conditions (333)

• Acantholytic variant squamous cell breast carcinoma
• Acinar lung adenocarcinoma
• Acinic cell breast carcinoma
• Adenoid cystic breast carcinoma
• Adenoma of nipple
• Adenosquamous breast carcinoma
• Adenosquamous lung carcinoma
• Adult pulmonary Langerhans cell histiocytosis
• Alveoli adenoma
• Asbestos-related lung carcinoma
• Askin tumor
• Atypical breast papilloma
• Atypical lobular breast hyperplasia
• Axillary lipoma
• Axillary neoplasm
• Basal-like breast carcinoma
• Basaloid large cell lung carcinoma
• Benign axillary neoplasm
• Benign breast adenomyoepithelioma
• Benign breast phyllodes tumor

Trials (121)

• (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
• (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
• (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
• A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
• A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy
• A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
• A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
• A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
• A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery
• A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
• A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC
• A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma
• A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
• A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
• A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
• A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Drugs in development (8)

• Carboplatin Phase 1
• Metformin Early phase 1
• Paclitaxel Phase 1
• Pembrolizumab Phase 1
• Pemetrexed Phase 1
• Pemetrexed disodium hemipentahydrate Phase 1
• Pemetrexed monohydrate Phase 1
• Sotorasib Phase 1